华领医药-B
港股通 官网
( 02552.hk)
市盈率2.78市净率2.83股息率0%上市时间2018-09-14股价3.11港币涨跌幅1.63%成交金额1,184.28万港币换手率0.36%市值32.86亿港币H股市值32.86亿港币总股本10.57亿H股本10.57亿每手股数500上市至今年化投资收益率-12.16%累计做空占H股比例0.31% (1,055.15万港币2026-03-13)
所属三级行业生物技术 (恒生) 市盈率286.62市净率4.44股息率0.41%恒生:医疗保健业药品及生物科技生物技术
备注 (2): 双击编辑备注
发表讨论

华领医药-B(02552) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1ZHANG YiExecutive Director2024-01-01--
2LI Fang XinNon Executive Director2023-10-12--
3張耀樑Independent Non Executive Director - A/F2023-01-01--
4趙瑋Non Executive Director2022-03-162023-10-12
5KELLER William RobertIndependent Non Executive Director2018-09-14--
6徐耀華Independent Non Executive Director2018-09-14--
7劉峻嶺Independent Non Executive Director2018-09-142023-03-31
8郭德明Independent Non Executive Director - A/F2018-09-142022-11-24
9林潔誠Executive Director2018-05-11--
10陳連勇Non Executive Director2015-01-062022-03-16
11陳力Executive Director2010-06-04--
12NELSEN Robert TaylorNon Executive Director2010-04-23--